Sable
London, United Kingdom
Sable Bio is developing a unique AI-enhanced platform designed to offer pharmaceutical companies predictive safety insights, mitigating the risk of clinical trial failures. Their innovative approach involves extracting proprietary signals from structured and unstructured data sources, leveraging large language models, causal inference techniques, and extensive domain knowledge.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2023
- Website
- sablebio.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Sable?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now